Immunofluorescence Assay Market Trends, Size and Insights by Technique (Primary, Secondary), by Product Type (Antibodies, Kits), by Application (Clinical research), End-User (Clinical Diagnostics, Hospitals & Research Institutes) - Global Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunofluorescence Assays Market, by Technique

6.1 Introduction

6.2 Primary (Direct) Immunofluorescence assays

6.2 Secondary (Indirect) Immunofluorescence assays

6.2.1 Salt split technique

6.2.2 Antigenic mapping method

6.2.3 Double Staining method

6.2 Micro Immunofluorescence

Chapter 7. Global Immunofluorescence Assays Market, by Product Type

7.1 Introduction

7.2 Antibodies

7.3 Kits and reagents

7.4 Instruments

7.4.1 Microscopes

7.4.2 Imaging Analysis Systems

7.5 Labeling dyes

7.6 Species Product Type

Chapter 8. Global Immunofluorescence Assays Market, by Application

8.1 Introduction

8.2 Clinical research

8.3 Clinical Diagnostics

8.3.1 Infectious Diseases

8.3.2 Cancer

8.3.3 Cardiovascular Diseases

8.3.4 Autoimmune Diseases

8.3.5 Neurological Diseases

8.3 Research & Development

Chapter 9. Global Immunofluorescence Assays Market, by End-User

9.1 Introduction

9.2 Biotechnology Companies

9.3 Hospitals & Research Institutes

9.4 Contract Research Organizations

9.4 Diagnostic centers

Chapter 10. Global Immunofluorescence Assays Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Abcam PLC

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Thermo Fisher Scientific

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 BioLegend, Inc

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Bio-Rad Laboratories

12.4.1 Company Overview

12.4.2 Product Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Enzo Life Sciences

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Sino Biological Inc

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 BIOTEK INSTRUMENTS, INC

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Zyagen

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Cell Signaling Technology, Inc

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 PerkinElmer Inc

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Becton Dickinson and Company

12.11.1 Overview

12.11.2 Product Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Merck

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Agilent Technologies

12.13.1 Overview

12.13.2 Product Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 TCS Biosciences Ltd

12.14.1 Overview

12.14.2 Product Type Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Maxvision Biosciences Inc

12.15.1 Overview

12.15.2 Product Type Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

12.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Immunofluorescence Assays Market Industry Synopsis, 2020-2027

Table 2 Global Immunofluorescence Assays Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Immunofluorescence Assays Market, by Region, 2020-2027, (USD Million)

Table 4 Global Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 5 Global Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 7 Global Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 8 Global Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million

Table 9 North America Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 10 North America Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 12 North America Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 13 North America Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 14 U.S. Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 15 U.S. Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 17 U.S. Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 18 U.S. Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 19 Canada Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 20 Canada Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 22 Canada Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 23 Canada Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 24 South America Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 25 South America Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 27 South America Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 28 South America Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 29 Europe Immunofluorescence Assays Market, Technique, 2020-2027, (USD Million)

Table 30 Europe Immunofluorescence Assays Market, Product Type, 2020-2027, (USD Million)

Table 32 Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 33 Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 34 Western Europe Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 35 Western Europe Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 37 Western Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 38 Western Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 39 Eastern Europe Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 40 Eastern Europe Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 42 Eastern Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 43 Eastern Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 44 Asia Pacific Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 45 Asia Pacific Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 47 Asia Pacific Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 48 Asia Pacific Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 49 The Middle East & Africa Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 50 The Middle East & Africa Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 52 The Middle East & Africa Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 53 The Middle East & Africa Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunofluorescence Assays Market

Figure 3 Market Dynamics for Global Immunofluorescence Assays Market

Figure 4 Global Immunofluorescence Assays Market Share, by Technique 2020

Figure 4 Global Immunofluorescence Assays Market Share, by Product Type 2020

Figure 5 Global Immunofluorescence Assays Market Share, by Application 2020

Figure 6 Global Immunofluorescence Assays Market Share, by End-User, 2020

Figure 7 Global Immunofluorescence Assays Market Share, by Region, 2020

Figure 8 North America Immunofluorescence Assays Market Share, by Country, 2020

Figure 9 Europe Immunofluorescence Assays Market Share, by Country, 2020

Figure 10 Asia Pacific Immunofluorescence Assays Market Share, by Country, 2020

Figure 11 Middle East & Africa Immunofluorescence Assays Market Share, by Country, 2020

Figure 12 Global Immunofluorescence Assays Market: Company Share Analysis, 2020 (%)

Figure 13 Abcam PLC: Key Financials

Figure 14 Abcam PLC: Segmental Revenue

Figure 15 Abcam PLC: Geographical Revenue

Figure 16 Thermo Fisher Scientific: Key Financials

Figure 17 Thermo Fisher Scientific: Segmental Revenue

Figure 18 Thermo Fisher Scientific: Geographical Revenue

Figure 19 BioLegend, Inc: Key Financials

Figure 20 BioLegend, Inc: Segmental Revenue

Figure 21 BioLegend, Inc: Geographical Revenue

Figure 22 Bio-Rad Laboratories: Key Financials

Figure 23 Bio-Rad Laboratories: Segmental Revenue

Figure 24 Bio-Rad Laboratories: Geographical Revenue

Figure 25 Sino Biological Inc: Key Financials

Figure 26 Sino Biological Inc: Segmental Revenue

Figure 27 Sino Biological Inc: Geographical Revenue

Figure 28 Enzo Life Sciences: Key Financials

Figure 29 Enzo Life Sciences: Segmental Revenue

Figure 30 Enzo Life Sciences: Geographical Revenue

Figure 31 BIOTEK INSTRUMENTS, INC: Key Financials

Figure 32 BIOTEK INSTRUMENTS, INC: Segmental Revenue

Figure 33 BIOTEK INSTRUMENTS, INC: Geographical Revenue

Figure 34 Zyagen: Key Financials

Figure 35 Zyagen: Segmental Revenue

Figure 36 Zyagen: Geographical Revenue

Figure 37 Cell Signaling Technology, Inc: Key Financials

Figure 38 Cell Signaling Technology, Inc: Segmental Revenue

Figure 39 Cell Signaling Technology, Inc: Geographical Revenue

Figure 40 PerkinElmer Inc: Key Financials

Figure 41 PerkinElmer Inc: Segmental Revenue

Figure 42 PerkinElmer Inc: Geographical Revenue

Figure 43 Maxvision Biosciences Inc: Key Financials

Figure 44 Maxvision Biosciences Inc: Segmental Revenue

Figure 45 Maxvision Biosciences Inc: Geographical Revenue

Figure 46 Becton Dickinson and Company: Key Financials

Figure 47 Becton Dickinson and Company: Segmental Revenue

Figure 48 Becton Dickinson and Company: Geographical Revenue

Figure 49 Merck: Key Financials

Figure 50 Merck: Segmental Revenue

Figure 51 Merck: Geographical Revenue

Figure 52 Agilent Technologies: Key Financials

Figure 53 Agilent Technologies: Segmental Revenue

Figure 54 Agilent Technologies: Geographical Revenue

Figure 55 TCS Biosciences Ltd: Key Financials

Figure 56 TCS Biosciences Ltd: Segmental Revenue

Figure 57 TCS Biosciences Ltd: Geographical Revenue